Kate Redwood
Direktor/Vorstandsmitglied bei Melbourne Health
Profil
Kate Redwood is currently a Director at Melbourne Health.
Previously, she worked as the Chief Executive Officer at the Australian Physiotherapy Association and as a Director at The Walter & Eliza Hall Institute of Medical Research.
She obtained an undergraduate degree from Monash University.
Aktive Positionen von Kate Redwood
| Unternehmen | Position | Beginn |
|---|---|---|
| Melbourne Health | Direktor/Vorstandsmitglied | 08.08.2011 |
Ehemalige bekannte Positionen von Kate Redwood
| Unternehmen | Position | Ende |
|---|---|---|
| Australian Physiotherapy Association | Präsident | - |
The Walter & Eliza Hall Institute of Medical Research
 The Walter & Eliza Hall Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services The Walter and Eliza Hall Institute of Medical Research provides medical research services. It undertakes research in a range of areas, preventing and treating diseases including breast, ovarian and blood cancers, type 1 diabetes, rheumatoid arthritis, coeliac disease and malaria. The firm’s research areas include bioinformatics, cancer biology, cell death, cell signaling, clinical translation, epigenetics, genomics, immunology, and inflammation and vaccine development. The company was founded in 1915 and is headquartered in Melbourne, Australia. | Direktor/Vorstandsmitglied | - |
Ausbildung von Kate Redwood
| Monash University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
The Walter & Eliza Hall Institute of Medical Research
The Walter & Eliza Hall Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services The Walter and Eliza Hall Institute of Medical Research provides medical research services. It undertakes research in a range of areas, preventing and treating diseases including breast, ovarian and blood cancers, type 1 diabetes, rheumatoid arthritis, coeliac disease and malaria. The firm’s research areas include bioinformatics, cancer biology, cell death, cell signaling, clinical translation, epigenetics, genomics, immunology, and inflammation and vaccine development. The company was founded in 1915 and is headquartered in Melbourne, Australia. | Commercial Services |
| Australian Physiotherapy Association | |
| Melbourne Health |
